期刊
LEUKEMIA & LYMPHOMA
卷 49, 期 1, 页码 36-41出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428190701684518
关键词
amyloidosis; multiple myeloma; restrictive cardiomyopathy; stem cell transplantation; troponin T
The efficacy of stem cell transplantation in amyloidosis largely is determined by treatment-related mortality rates (range, 11-25%). Appropriate patient selection is essential to avoid this high mortality rate. Among 271 patients undergoing stem cell transplantation, troponin T was a powerful predictor of treatment-related mortality. Patients with troponin T levels of 0.06g/L or higher had a day-100 all-cause mortality rate of 28%. Patients with troponin T levels less than 0.06g/L had a day-100 all-cause mortality rate of 7% (P0.001). Troponin T levels should be measured in all patients before transplantation. Those with troponin T levels exceeding 0.06g/L should be considered for less toxic therapies until the clinically optimal use of stem cell transplantation is better defined by randomized clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据